Scientists at Johns Hopkins learned how the eye makes the sharpest vision before a baby is born. They found that a vitamin A‑derived chemical and thyroid hormones work together in the retina.
Lab‑grown eye pieces show the secret
The team grew tiny retinal organoids from fetal cells. These organoids act like a mini‑retina and let researchers watch development over months.
They focused on the foveola – the tiny spot in the centre of the retina that gives us the clearest view. Though it is very small, the foveola provides about half of all what we see.
Special light‑sensing cells called cones
Cones are the cells that let us see colour and details in daylight. In the whole retina there are three cone types: blue, green, and red. In the foveola only red and green cones remain.
How the cone pattern changes
During weeks 10‑12 of fetal growth, a few blue cones appear in the foveola. By week 14 those blue cones turn into red and green cones.
Two steps cause this change. First, retinoic acid – a molecule made from vitamin A – breaks down, stopping new blue cones from forming. Then thyroid hormone tells the existing blue cones to become red or green.
Why this matters
For many years scientists thought the blue cones moved away from the centre, leaving space for red and green cones. The new work shows the blue cones stay put and simply change their identity.
Future hopes for eye disease
Understanding this process could help create better treatments for diseases that hurt the retina, such as macular degeneration and glaucoma.
Researchers plan to improve organoids so they act even more like a real human retina. One goal is to grow healthy photoreceptor cells that could be transplanted into damaged eyes.
Such cell‑replacement therapy could one day bring back lost sight, but many safety tests are still needed before doctors can try it in patients.